David Domzalski
2020
In 2020, David Domzalski earned a total compensation of $2.9M as President and Chief Executive Officer at VYNE Therapeutics.
Compensation breakdown
| Bonus | $277,200 |
|---|---|
| Option Awards | $756,908 |
| Salary | $500,500 |
| Stock Awards | $1,326,000 |
| Other | $11,400 |
| Total | $2,872,008 |
Domzalski received $1.3M in stock awards, accounting for 46% of the total pay in 2020.
Domzalski also received $277.2K in bonus, $756.9K in option awards, $500.5K in salary and $11.4K in other compensation.
Rankings
In 2020, David Domzalski's compensation ranked 4,032nd out of 13,090 executives tracked by ExecPay. In other words, Domzalski earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,032 out of 13,090 | 69th |
Division Manufacturing | 1,626 out of 5,618 | 71st |
Major group Chemicals And Allied Products | 622 out of 2,251 | 72nd |
Industry group Drugs | 535 out of 1,951 | 73rd |
Industry Pharmaceutical Preparations | 408 out of 1,456 | 72nd |
Source: SEC filing on June 7, 2021.
Domzalski's colleagues
We found three more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2020.